Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deficient natural killer cell function in preeclampsia.

A Alanen, O Lassila

    Obstetrics and Gynecology
    |November 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    BLIMP-1 is insufficient to induce antibody secretion in the absence of IRF4 in DT40 cells.

    Scandinavian journal of immunology·2018
    Same author

    IRF4 Deficiency Leads to Altered BCR Signalling Revealed by Enhanced PI3K Pathway, Decreased SHIP Expression and Defected Cytoskeletal Responses.

    Scandinavian journal of immunology·2015
    Same author

    Regulation of B Cell to Plasma Cell Transition within the Follicular B Cell Response.

    Scandinavian journal of immunology·2015
    Same author

    Clinical audit: Development of the criteria of good practices.

    Radiation protection dosimetry·2011
    Same author

    Gene interaction network regulates plasma cell differentiation.

    Scandinavian journal of immunology·2011
    Same author

    Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.

    Neurology·2010
    Same journal

    The Political Determinants of Obstetric Prescribing.

    Obstetrics and gynecology·2026
    Same journal

    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

    Obstetrics and gynecology·2026
    Same journal

    Milestones in Motion: Vaginal Birth After Cesarean.

    Obstetrics and gynecology·2026
    Same journal

    Ebola Virus in Pregnancy.

    Obstetrics and gynecology·2026
    Same journal

    A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

    Obstetrics and gynecology·2026
    Same journal

    The Effects of Climate Change on Obstetric and Gynecologic Health.

    Obstetrics and gynecology·2026
    See all related articles

    Natural killer cell activity is reduced in preeclamptic women, indicating a potential role for the maternal immune system in preeclampsia. These cells still respond to interferon, suggesting specific immune system dysfunctions.

    Area of Science:

    • Immunology
    • Obstetrics
    • Perinatology

    Background:

    • Preeclampsia is a serious pregnancy complication.
    • The maternal immune system's role in preeclampsia is not fully understood.

    Purpose of the Study:

    • To investigate natural killer (NK) cell activity in women with preeclampsia.
    • To compare NK cell activity in preeclamptic women with healthy pregnant and non-pregnant controls.

    Main Methods:

    • Peripheral blood lymphocytes from 15 preeclamptic women, 19 healthy pregnant women, and 18 non-pregnant women were analyzed.
    • Natural killer cell activity was measured using a 4-hour 51Cr release assay against K-562 target cells.
    • NK cell response to interferon augmentation was also assessed.

    Main Results:

    Related Experiment Videos

    • Natural killer cell activity was significantly lower in preeclamptic women compared to both control groups.
    • Natural killer cells from preeclamptic women showed a normal response to interferon-induced augmentation.
    • These findings suggest a specific impairment in NK cell function in preeclampsia.

    Conclusions:

    • The maternal immune system, specifically natural killer cell activity, appears to be involved in the pathophysiology of preeclampsia.
    • Further research is warranted to explore therapeutic strategies targeting immune system modulation in preeclampsia.